Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis.

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (2008) 33.10

Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08

Interaction revisited: the difference between two estimates. BMJ (2003) 11.97

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 10.75

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.12

British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax (2003) 5.83

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.57

GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). J Clin Epidemiol (2011) 5.10

Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost (2007) 4.09

GRADE guidelines 6. Rating the quality of evidence--imprecision. J Clin Epidemiol (2011) 3.54

GRADE guidelines: 5. Rating the quality of evidence--publication bias. J Clin Epidemiol (2011) 3.44

Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials. BMJ (2011) 3.28

GRADE guidelines: 7. Rating the quality of evidence--inconsistency. J Clin Epidemiol (2011) 3.02

GRADE guidelines: 8. Rating the quality of evidence--indirectness. J Clin Epidemiol (2011) 2.83

Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid. J Clin Epidemiol (2011) 2.69

The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis. Arch Intern Med (2003) 2.33

The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica (2007) 2.00

GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol (2012) 1.90

GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. J Clin Epidemiol (2012) 1.75

Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ (2008) 1.71

Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med (2010) 1.68

Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers. PLoS One (2013) 1.40

The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica (1997) 1.39

Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting. J Thromb Haemost (2010) 0.89

What is the optimal duration of treatment for DVT? An update on evidence-based medicine of treatment for DVT. Semin Vasc Surg (2010) 0.88

A conceptual framework for two phases of anticoagulant treatment of venous thromboembolism. J Thromb Haemost (2012) 0.88

Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA (2014) 2.59

Legislative, educational, policy and other interventions targeting physicians' interaction with pharmaceutical companies: a systematic review. BMJ Open (2014) 0.96

Requirements of Clinical Journals for Authors' Disclosure of Financial and Non-Financial Conflicts of Interest: A Cross Sectional Study. PLoS One (2016) 0.92

Systematic review of observational studies assessing bleeding risk in patients with atrial fibrillation not using anticoagulants. PLoS One (2014) 0.77

The fragility of statistically significant findings from randomized trials in spine surgery: a systematic survey. Spine J (2015) 0.76

Compression Stockings for Preventing the Postthrombotic Syndrome in Patients with Deep Vein Thrombosis. Am J Med (2015) 0.76

Multilayered and digitally structured presentation formats of trustworthy recommendations: a combined survey and randomised trial. BMJ Open (2017) 0.75

Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol. BMJ Open (2016) 0.75

Hemicraniectomy versus medical treatment with large MCA infarct: a review and meta-analysis. BMJ Open (2016) 0.75

Reporting of financial and non-financial conflicts of interest by authors of systematic reviews: a methodological survey. BMJ Open (2016) 0.75

Brazilian medicinal plants to treat upper respiratory tract and bronchial illness: systematic review and meta-analyses-study protocol. BMJ Open (2014) 0.75

Characteristics of funding of clinical trials: cross-sectional survey and proposed guidance. BMJ Open (2017) 0.75

Sex differences and adverse events of antiretrovirals in people living with HIV/AIDS: a systematic review and meta-analysis protocol. BMJ Open (2022) 0.75

Use of IMMPACT domains in clinical trials of acupuncture for chronic pain: a protocol for a methodological survey. BMJ Open (2017) 0.75

Gap Between Official Guidelines and Clinical Practice for the Treatment of Rheumatoid Arthritis in São Paulo, Brazil. Clin Ther (2016) 0.75

Tranexamic acid versus placebo to reduce perioperative blood transfusion in patients undergoing liver resection: protocol for the haemorrhage during liver resection tranexamic acid (HeLiX) randomised controlled trial. BMJ Open (2022) 0.75